Description

Reneuro (Choline Alfoscerate) Solution for Injections 250 mg/ml. 4 ml Ampoules №10

Ingredients:

Each 4 ml ampoule contains 1000 mg of Choline Alfoscerate.

Dosage:

The recommended dosage is determined by a healthcare professional based on individual needs. Reneuro is typically administered via intramuscular or intravenous injection.

Indications:

Reneuro is indicated for the treatment of cognitive disorders and memory impairment associated with various conditions. It may also be used in the management of certain neurological disorders.

Contraindications:

Do not use Reneuro if you are allergic to choline alfoscerate or any other ingredients in the solution. It is important to consult with a healthcare provider before starting treatment.

Directions:

Administer Reneuro as directed by a healthcare professional. The solution should be visually inspected for particulate matter and discoloration before administration.

Scientific Evidence:

Choline alfoscerate, the active ingredient in Reneuro, has been studied for its cognitive-enhancing properties. Research suggests that choline alfoscerate may improve memory, attention, and overall cognitive function.

In a double-blind, placebo-controlled study published in the Journal of Clinical Psychopharmacology, choline alfoscerate was found to significantly improve cognitive performance in patients with cognitive impairment.

Additional Information:

Reneuro is well-tolerated in most individuals, with minimal side effects reported. However, it is essential to discuss any existing medical conditions or medications with a healthcare provider before using Reneuro.

For more information on the pharmacological effects and clinical trials of Reneuro, consult published research studies and medical literature for comprehensive insights into its efficacy and safety profile.